Browsing byAuthorJarolimek, W
Showing results 1 to 6 of 6
| Issue Date | Title | Author(s) |
| 2017-04-21 | The effect of non-specific tight junction modulators on the transepithelial transport of poorly permeable drugs across airway epithelial cells | Ghadiri, M; Young, PM; Jarolimek, W; Grau, GER; Oliver, BGG; Traini, D |
| 2015-03-20 | Effects of an anti-inflammatory VAP-1/SSAO inhibitor, PXS-4728A, on pulmonary neutrophil migration | Schilter, HC; Collison, A; Russo, RC; Foot, JS; Yow, TT; Vieira, AT; Tavares, LD; Mattes, J; Teixeira, MM; Jarolimek, W |
| 2019-11-14 | Identification and Optimization of Mechanism-Based Fluoroallylamine Inhibitors of Lysyl Oxidase-like 2/3 | Findlay, AD; Foot, JS; Buson, A; Deodhar, M; Jarnicki, AG; Hansbro, PM; Liu, G; Schilter, H; Turner, CI; Zhou, W; Jarolimek, W |
| 2021-06-14 | Lysyl oxidase inhibitors attenuate cyclosporin A-induced nephropathy in mouse. | Nguyen, LT; Saad, S; Shi, Y; Wang, R; Chou, ASY; Gill, A; Yao, Y; Jarolimek, W; Pollock, CA |
| 2015-06-01 | The mannose-6-phosphate analogue, PXS64, inhibits fibrosis via TGF-β1 pathway in human lung fibroblasts | Schilter, H; Cantemir-Stone, CZ; Leksa, V; Ohradanova-Repic, A; Findlay, AD; Deodhar, M; Stockinger, H; Song, X; Molloy, M; Marsh, CB; Jarolimek, W |
| 2016-11 | The inhibitor of semicarbazide-sensitive amine oxidase, PXS-4728A, ameliorates key features of chronic obstructive pulmonary disease in a mouse model. | Jarnicki, AG; Schilter, H; Liu, G; Wheeldon, K; Essilfie, A-T; Foot, JS; Yow, TT; Jarolimek, W; Hansbro, PM |
